Education
About Us
Working with TipRanks
Follow Us
Martin A. Lehr Insider Profile
4 Followers
Martin A. Lehr, CEO, Director at Context Therapeutics, holds 979.89K shares in Context Therapeutics (Ticker: CNTX).
Martin A. Lehr Context Therapeutics (CNTX)CEO, Director
Context Therapeutics (CNTX)
CEO, Director
Ranked #88,416 out of 100,956 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-37.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Martin A. Lehr holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 19, 2022 - Dec 19, 2023
Return:+60.00%
The most profitable trade made by Martin A. Lehr
Martin A. Lehr's Trading History
List of latest transactions for each holding click on a transaction to see Martin A. Lehr's performance on stock
You May Also Like
Martin A. Lehr insider profile FAQ
What is the percentage of profitable transactions made by Martin A. Lehr?
The percentage of profitable transactions made by Martin A. Lehr is 25%.
What is the average return per transaction made by Martin A. Lehr?
The average return per transaction made by Martin A. Lehr is -37.70%.
What stocks does Martin A. Lehr hold?
Martin A. Lehr holds: CNTX stocks.
What was Martin A. Lehr’s latest transaction?
Martin A. Lehr latest transaction was an Uninformative Buy of $4.89K.
What was Martin A. Lehr's most profitable transaction?
Martin A. Lehr’s most profitable transaction was an Informative Buy of CNTX stock on December 19, 2022. The return on the trade was 60.00%.
What is Martin A. Lehr's role in Context Therapeutics?
Martin A. Lehr's role in Context Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.